{
  "id": "mhgap#referral_306ca762",
  "content": "y Most weight gain was produced by clozapine, in adolescents.\nquetiapine and olanzapine.\nImplementation considerations\ny For prolactin increase, aripiprazole and asenapine\nshowed the lowest prolactin increase. Quetiapine, y Only a few antipsychotics are officially licensed\npaliperidone, olanzapine, haloperidol and for children and adolescents which should be\nrisperidone showed significantly higher prolactin considered in medicine choice, taking into account\nincrease than placebo. Risperidone and haloperidol the country and context.\nshowed the largest prolactin increase compared y Antipsychotic medicine should be considered for\nwith the placebo. adolescents with psychotic disorders only under\ny Concerning the outcome sedation, most medicines supervision of a mental health specialist.\nproduced this outcome. Risperidone, aripiprazole, y Adolescents are more susceptible to side-effects\nhaloperidol, olanzapine, loxapine, paliperidone, from antipsychotic medicines than adults. In\nasenapine and clozapine led to significantly more turn, during the clinical decision-making process,\nsedation than placebo. adolescents living with psychosis should be made\ny The use of anticholinergic medicine was significantly aware of benefits and side-effects so that they\nhigher for paliperidone compared with placebo. are able to make informed choices regarding the\ntreatment plan. Additionally, carer preference\nRemarks should be taken into consideration.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Referral y Most weight gain was produced by clozapine, in adolescents.\nquetiapine and olanzapine.\nImplementation considerations\ny For prolactin increase, aripiprazole and asenapine\nshowed the lowest prolactin increase. Quetiapine, y Only a few antipsychotics are officially licensed\npaliperidone, olanzapine, haloperidol and for children and adolescents which should be\nrisperidone showed significantly higher prolactin considered in medicine choice, taking into account\nincrease than placebo. Risperidone and haloperidol the country and context.\nshowed the largest prolactin increase compared y Antipsychotic medicine should be considered for\nwith the placebo. adolescents with psychotic disorders only under\ny Concerning the outcome sedation, most medicines supervision of a mental health specialist.\nproduced this outcome. Risperidone, aripiprazole, y Adolescents are more susceptible to side-effects\nhaloperidol, olanzapine, loxapine, paliperidone, from antipsychotic medicines than adults. In\nasenapine and clozapine led to significantly more turn, during the clinical decision-making process,\nsedation than placebo. adolescents living with psychosis should be made\ny The use of anticholinergic medicine was significantly aware of benefits and side-effects so that they\nhigher for paliperidone compared with placebo. are able to make informed choices regarding the\ntreatment plan. Additionally, carer preference\nRemarks should be taken into consideration. Y most weight gain was produced by clozapine, in adolescents. quetiapine and olanzapine."
}